Cryoballoon Ablation for Early Persistent Atrial Fibrillation (Cryo4 Persistent AF)

NACompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

December 8, 2014

Primary Completion Date

June 22, 2017

Study Completion Date

September 12, 2017

Conditions
Atrial Fibrillation
Interventions
OTHER

Holter monitoring

Subjects will wear holter monitors at baseline, 6 months and 12 months.

Trial Locations (14)

10117

Charite - Universitaetsmedizin, Berlin

11526

Henry Dunant Hospital Center, Athens

Unknown

Hôpital Henri Mondor, Créteil

CHU de Grenoble, Grenoble

CHU de la Timone, Marseille

CHU - Hôpitaux de Rouen, Rouen

Clinique Pasteur, Toulouse

Herz- und Diabeteszentrum NRW, Bad Oeynhausen

Krankenhaus Porz am Rhein, Cologne

St. Vinzenz-Hospital, Cologne

Cardioangiologisches Centrum Bethanien, Frankfurt

Asklepios Klinik St. Georg, Hamburg

Klinikum Nürnberg Süd, Nuremberg

Uniklinik Ulm, Ulm

All Listed Sponsors
lead

Medtronic Cardiac Ablation Solutions

INDUSTRY

NCT02213731 - Cryoballoon Ablation for Early Persistent Atrial Fibrillation (Cryo4 Persistent AF) | Biotech Hunter | Biotech Hunter